世界のオキサリプラチン市場:成長動向・競争分析2020-2026

【英語タイトル】Global Oxaliplatin Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP01716)・商品コード:QYR20AP01716
・発行会社(調査会社):QYResearch
・発行日:2020年3月20日(※2024年版があります。お問い合わせください)
・ページ数:144
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、オキサリプラチンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、オキサリプラチンのグローバル市場動向、メーカー別競争状況、種類別市場規模(マンニトール、ブドウ糖液、乳糖液、その他)、用途別市場規模(大腸がん、胃がん、卵巣がん、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・オキサリプラチンの種類別市場2015-2026:マンニトール、ブドウ糖液、乳糖液、その他
・オキサリプラチンの用途別市場2015-2026:大腸がん、胃がん、卵巣がん、その他
・オキサリプラチンの北米市場分析
・オキサリプラチンのアジア市場分析
・オキサリプラチンの中南米市場分析
・オキサリプラチンの中東・アフリカ市場分析
・関連企業情報:Sanofi-Aventis、Yakult honsha、Dr Reddy's laboratories、Sun Pharmaceutical、Teva、Fresenius Kabi、Hospira、Mylan、Jiangsu Hengrui Medicine、Nanjing Pharmaceutical Factory、Jiangsu Aosaikang Pharmaceutical、Qilu Pharmaceutical、Hisun Pharmaceutical、Lunan Pharmaceutical、Luoxin、Halfsky Pharmacy、YRPG、Hainan Jinrui Pharmaceutical、Jari Pharmaceutical、Chiatai Tianqing
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.
In this report, only the finished drug is covered, exclude API.
The Oxaliplatin concentration is high; there are many manufacturers in the world, and high-end products mainly from USA and Europe. In the world wide, giant manufactures mainly distribute in US, Europe and China such as Sanofi-Aventis, Yakult honsha, Dr Reddy’s laboratories, Teva and Jiangsu Hengrui Medicine.
In 2019, the global Oxaliplatin market size was US$ 848.8 million and is forecast to US$ 976.5 million in 2026, growing at a CAGR of 2.0% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Oxaliplatin.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Oxaliplatin market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Oxaliplatin market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Oxaliplatin market. Readers of the report can become informed about current and future trends of the global Oxaliplatin market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Oxaliplatin markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Oxaliplatin market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Oxaliplatin market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Oxaliplatin market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Oxaliplatin market is segmented into
Mannitol
Glucose Solution
Lactose Solution
Other

Market Segment by Application, the Oxaliplatin market is segmented into
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Other

This report includes the following manufacturers; we can also add the other companies as you want.
Sanofi-Aventis
Yakult honsha
Dr Reddy’s laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing

The study objectives are:
To analyze and research the global Oxaliplatin status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Oxaliplatin manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Oxaliplatin are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Oxaliplatin Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Oxaliplatin Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Mannitol
1.3.3 Glucose Solution
1.3.4 Lactose Solution
1.3.5 Other
1.4 Market Segment by Application
1.4.1 Global Oxaliplatin Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Colorectal Cancer
1.4.3 Stomach Cancer
1.4.4 Ovarian Cancer
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Oxaliplatin Revenue (2015-2026)
2.1.1 Global Oxaliplatin Revenue (2015-2026)
2.1.2 Global Oxaliplatin Sales (2015-2026)
2.2 Oxaliplatin Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Oxaliplatin Sales by Regions (2015-2020)
2.2.2 Global Oxaliplatin Revenue by Regions (2015-2020)
2.3 Global Top Oxaliplatin Regions (Countries) Ranking by Market Size
2.4 Oxaliplatin Industry Trends
2.4.1 Oxaliplatin Market Top Trends
2.4.2 Market Drivers
2.4.3 Oxaliplatin Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Oxaliplatin Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Oxaliplatin Manufacturers by Sales (2015-2020)
3.1.1 Global Oxaliplatin Sales by Manufacturers (2015-2020)
3.1.2 Global Oxaliplatin Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Oxaliplatin Sales in 2019
3.2 Global Top Manufacturers Oxaliplatin by Revenue
3.2.1 Global Oxaliplatin Revenue by Manufacturers (2015-2020)
3.2.2 Global Oxaliplatin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oxaliplatin Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxaliplatin as of 2019)
3.4 Global Oxaliplatin Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Oxaliplatin Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Oxaliplatin Market
3.7 Key Manufacturers Oxaliplatin Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Oxaliplatin Historic Market Review by Type (2015-2020)
4.1.2 Global Oxaliplatin Sales Market Share by Type (2015-2020)
4.1.3 Global Oxaliplatin Revenue Market Share by Type (2015-2020)
4.1.4 Oxaliplatin Price by Type (2015-2020)
4.1 Global Oxaliplatin Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Oxaliplatin Sales Forecast by Type (2021-2026)
4.2.3 Global Oxaliplatin Revenue Forecast by Type (2021-2026)
4.2.4 Oxaliplatin Price Forecast by Type (2021-2026)

5 Global Oxaliplatin Market Size by Application
5.1 Global Oxaliplatin Historic Market Review by Application (2015-2020)
5.1.2 Global Oxaliplatin Sales Market Share by Application (2015-2020)
5.1.3 Global Oxaliplatin Revenue Market Share by Application (2015-2020)
5.1.4 Oxaliplatin Price by Application (2015-2020)
5.2 Global Oxaliplatin Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Oxaliplatin Sales Forecast by Application (2021-2026)
5.2.3 Global Oxaliplatin Revenue Forecast by Application (2021-2026)
5.2.4 Oxaliplatin Price Forecast by Application (2021-2026)

6 North America
6.1 North America Oxaliplatin Breakdown Data by Company
6.2 North America Oxaliplatin Breakdown Data by Type
6.3 North America Oxaliplatin Breakdown Data by Application
6.4 North America Oxaliplatin Breakdown Data by Countries
6.4.1 North America Oxaliplatin Sales by Countries
6.4.2 North America Oxaliplatin Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Oxaliplatin Breakdown Data by Company
7.2 Europe Oxaliplatin Breakdown Data by Type
7.3 Europe Oxaliplatin Breakdown Data by Application
7.4 Europe Oxaliplatin Breakdown Data by Countries
7.4.1 Europe Oxaliplatin Sales by Countries
7.4.2 Europe Oxaliplatin Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Oxaliplatin Breakdown Data by Company
8.2 Asia Pacific Oxaliplatin Breakdown Data by Type
8.3 Asia Pacific Oxaliplatin Breakdown Data by Application
8.4 Asia Pacific Oxaliplatin Breakdown Data by Regions
8.4.1 Asia Pacific Oxaliplatin Sales by Regions
8.4.2 Asia Pacific Oxaliplatin Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Oxaliplatin Breakdown Data by Company
9.2 Latin America Oxaliplatin Breakdown Data by Type
9.3 Latin America Oxaliplatin Breakdown Data by Application
9.4 Latin America Oxaliplatin Breakdown Data by Countries
9.4.1 Latin America Oxaliplatin Sales by Countries
9.4.2 Latin America Oxaliplatin Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Oxaliplatin Breakdown Data by Type
10.2 Middle East and Africa Oxaliplatin Breakdown Data by Application
10.3 Middle East and Africa Oxaliplatin Breakdown Data by Countries
10.3.1 Middle East and Africa Oxaliplatin Sales by Countries
10.3.2 Middle East and Africa Oxaliplatin Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Corporation Information
11.1.2 Sanofi-Aventis Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Sanofi-Aventis Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Sanofi-Aventis Oxaliplatin Products and Services
11.1.5 Sanofi-Aventis SWOT Analysis
11.1.6 Sanofi-Aventis Recent Developments
11.2 Yakult honsha
11.2.1 Yakult honsha Corporation Information
11.2.2 Yakult honsha Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Yakult honsha Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Yakult honsha Oxaliplatin Products and Services
11.2.5 Yakult honsha SWOT Analysis
11.2.6 Yakult honsha Recent Developments
11.3 Dr Reddy’s laboratories
11.3.1 Dr Reddy’s laboratories Corporation Information
11.3.2 Dr Reddy’s laboratories Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Dr Reddy’s laboratories Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Dr Reddy’s laboratories Oxaliplatin Products and Services
11.3.5 Dr Reddy’s laboratories SWOT Analysis
11.3.6 Dr Reddy’s laboratories Recent Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Corporation Information
11.4.2 Sun Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Sun Pharmaceutical Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Sun Pharmaceutical Oxaliplatin Products and Services
11.4.5 Sun Pharmaceutical SWOT Analysis
11.4.6 Sun Pharmaceutical Recent Developments
11.5 Teva
11.5.1 Teva Corporation Information
11.5.2 Teva Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Teva Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Teva Oxaliplatin Products and Services
11.5.5 Teva SWOT Analysis
11.5.6 Teva Recent Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Corporation Information
11.6.2 Fresenius Kabi Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Fresenius Kabi Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Fresenius Kabi Oxaliplatin Products and Services
11.6.5 Fresenius Kabi SWOT Analysis
11.6.6 Fresenius Kabi Recent Developments
11.7 Hospira
11.7.1 Hospira Corporation Information
11.7.2 Hospira Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Hospira Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Hospira Oxaliplatin Products and Services
11.7.5 Hospira SWOT Analysis
11.7.6 Hospira Recent Developments
11.8 Mylan
11.8.1 Mylan Corporation Information
11.8.2 Mylan Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Mylan Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Mylan Oxaliplatin Products and Services
11.8.5 Mylan SWOT Analysis
11.8.6 Mylan Recent Developments
11.9 Jiangsu Hengrui Medicine
11.9.1 Jiangsu Hengrui Medicine Corporation Information
11.9.2 Jiangsu Hengrui Medicine Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Jiangsu Hengrui Medicine Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Jiangsu Hengrui Medicine Oxaliplatin Products and Services
11.9.5 Jiangsu Hengrui Medicine SWOT Analysis
11.9.6 Jiangsu Hengrui Medicine Recent Developments
11.10 Nanjing Pharmaceutical Factory
11.10.1 Nanjing Pharmaceutical Factory Corporation Information
11.10.2 Nanjing Pharmaceutical Factory Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Products and Services
11.10.5 Nanjing Pharmaceutical Factory SWOT Analysis
11.10.6 Nanjing Pharmaceutical Factory Recent Developments
11.11 Jiangsu Aosaikang Pharmaceutical
11.11.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
11.11.2 Jiangsu Aosaikang Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Products and Services
11.11.5 Jiangsu Aosaikang Pharmaceutical SWOT Analysis
11.11.6 Jiangsu Aosaikang Pharmaceutical Recent Developments
11.12 Qilu Pharmaceutical
11.12.1 Qilu Pharmaceutical Corporation Information
11.12.2 Qilu Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Qilu Pharmaceutical Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Qilu Pharmaceutical Oxaliplatin Products and Services
11.12.5 Qilu Pharmaceutical SWOT Analysis
11.12.6 Qilu Pharmaceutical Recent Developments
11.13 Hisun Pharmaceutical
11.13.1 Hisun Pharmaceutical Corporation Information
11.13.2 Hisun Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.13.3 Hisun Pharmaceutical Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 Hisun Pharmaceutical Oxaliplatin Products and Services
11.13.5 Hisun Pharmaceutical SWOT Analysis
11.13.6 Hisun Pharmaceutical Recent Developments
11.14 Lunan Pharmaceutical
11.14.1 Lunan Pharmaceutical Corporation Information
11.14.2 Lunan Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.14.3 Lunan Pharmaceutical Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.14.4 Lunan Pharmaceutical Oxaliplatin Products and Services
11.14.5 Lunan Pharmaceutical SWOT Analysis
11.14.6 Lunan Pharmaceutical Recent Developments
11.15 Luoxin
11.15.1 Luoxin Corporation Information
11.15.2 Luoxin Business Overview and Total Revenue (2019 VS 2018)
11.15.3 Luoxin Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.15.4 Luoxin Oxaliplatin Products and Services
11.15.5 Luoxin SWOT Analysis
11.15.6 Luoxin Recent Developments
11.16 Halfsky Pharmacy
11.16.1 Halfsky Pharmacy Corporation Information
11.16.2 Halfsky Pharmacy Business Overview and Total Revenue (2019 VS 2018)
11.16.3 Halfsky Pharmacy Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.16.4 Halfsky Pharmacy Oxaliplatin Products and Services
11.16.5 Halfsky Pharmacy SWOT Analysis
11.16.6 Halfsky Pharmacy Recent Developments
11.17 YRPG
11.17.1 YRPG Corporation Information
11.17.2 YRPG Business Overview and Total Revenue (2019 VS 2018)
11.17.3 YRPG Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.17.4 YRPG Oxaliplatin Products and Services
11.17.5 YRPG SWOT Analysis
11.17.6 YRPG Recent Developments
11.18 Hainan Jinrui Pharmaceutical
11.18.1 Hainan Jinrui Pharmaceutical Corporation Information
11.18.2 Hainan Jinrui Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.18.4 Hainan Jinrui Pharmaceutical Oxaliplatin Products and Services
11.18.5 Hainan Jinrui Pharmaceutical SWOT Analysis
11.18.6 Hainan Jinrui Pharmaceutical Recent Developments
11.19 Jari Pharmaceutical
11.19.1 Jari Pharmaceutical Corporation Information
11.19.2 Jari Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.19.3 Jari Pharmaceutical Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.19.4 Jari Pharmaceutical Oxaliplatin Products and Services
11.19.5 Jari Pharmaceutical SWOT Analysis
11.19.6 Jari Pharmaceutical Recent Developments
11.20 Chiatai Tianqing
11.20.1 Chiatai Tianqing Corporation Information
11.20.2 Chiatai Tianqing Business Overview and Total Revenue (2019 VS 2018)
11.20.3 Chiatai Tianqing Oxaliplatin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.20.4 Chiatai Tianqing Oxaliplatin Products and Services
11.20.5 Chiatai Tianqing SWOT Analysis
11.20.6 Chiatai Tianqing Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Oxaliplatin Sales Channels
12.2.2 Oxaliplatin Distributors
12.3 Oxaliplatin Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Oxaliplatin Sales Forecast (2021-2026)
13.1.1 Global Oxaliplatin Sales Forecast by Regions (2021-2026)
13.1.2 Global Oxaliplatin Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Oxaliplatin Sales Forecast (2021-2026)
13.2.2 North America Oxaliplatin Revenue Forecast (2021-2026)
13.2.3 North America Oxaliplatin Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Oxaliplatin Sales Forecast (2021-2026)
13.3.2 Europe Oxaliplatin Revenue Forecast (2021-2026)
13.3.3 Europe Oxaliplatin Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Oxaliplatin Sales Forecast (2021-2026)
13.4.2 Asia Pacific Oxaliplatin Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Oxaliplatin Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Oxaliplatin Sales Forecast (2021-2026)
13.5.2 Latin America Oxaliplatin Revenue Forecast (2021-2026)
13.5.3 Latin America Oxaliplatin Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Oxaliplatin Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Oxaliplatin Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Oxaliplatin Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Oxaliplatin Key Market Segments
Table 2. Ranking of Global Top Oxaliplatin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oxaliplatin Market Size Growth Rate by Type 2021-2026 (MT) & (Million US$)
Table 4. Major Manufacturers of Mannitol
Table 5. Major Manufacturers of Glucose Solution
Table 6. Major Manufacturers of Lactose Solution
Table 7. Major Manufacturers of Other
Table 8. Global Oxaliplatin Market Share by Application 2019-2025 (MT)
Table 9. Global Oxaliplatin Market Size by Regions 2015-2020 (MT) & (Million US$)
Table 10. Global Oxaliplatin Sales by Regions 2015-2020 (MT)
Table 11. Global Oxaliplatin Sales Market Share by Regions 2015-2020
Table 12. Global Oxaliplatin Revenue by Regions 2015-2020 (Million US$)
Table 13. Global Oxaliplatin Revenue Market Share by Regions 2015-2020
Table 14. Top Oxaliplatin Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 15. Market Top Trends
Table 16. Oxaliplatin Key Drivers: Impact Analysis (2021-2026)
Table 17. Oxaliplatin Key Challenges
Table 18. Main Points Interviewed from Key Oxaliplatin Players: Views for Future
Table 19. Global Oxaliplatin Sales by Manufacturers (2015-2020) (MT)
Table 20. Global Oxaliplatin Sales Share by Manufacturers (2015-2020)
Table 21. Oxaliplatin Revenue by Manufacturers (2015-2020) (Million US$)
Table 22. Oxaliplatin Revenue Share by Manufacturers (2015-2020)
Table 23. Global Oxaliplatin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxaliplatin as of 2019)
Table 25. Key Manufacturers Oxaliplatin Average Selling Price (ASP) (2015-2020) (USD/MT)
Table 26. Key Manufacturers Oxaliplatin Plants/Factories Distribution
Table 27. Key Manufacturers Oxaliplatin Area Served
Table 28. Date of Key Manufacturers Enter into Oxaliplatin Market
Table 29. Key Manufacturers Oxaliplatin Product Type
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Mannitol Sales and Revenue (2015-2020) (MT) & (Million US$)
Table 32. Global Glucose Solution Sales and Revenue (2015-2020) (MT) & (Million US$)
Table 33. Global Lactose Solution Sales ana Revenue (2015-2020) (MT) & (Million US$)
Table 34. Global Other Sales ana Revenue (2015-2020) (MT) & (Million US$)
Table 35. Global Oxaliplatin Sales (MT) by Type (2015-2020)
Table 36. Global Oxaliplatin Sales Share by Type (2015-2020)
Table 37. Global Oxaliplatin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 38. Global Oxaliplatin Price (MT) by Type (2015-2020)
Table 39. Global Oxaliplatin Sales (MT) by Type (2021-2026)
Table 40. Global Oxaliplatin Sales Share by Type (2021-2026)
Table 41. Global Oxaliplatin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 42. Global Oxaliplatin Revenue Share by Type (2021-2026)
Table 43. Global Oxaliplatin Price (MT) by Type (2021-2026)
Table 44. Global Oxaliplatin Sales (MT) by Application (2015-2020)
Table 45. Global Oxaliplatin Sales Share by Application (2015-2020)
Table 46. Global Oxaliplatin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 47. Global Oxaliplatin Price by Application 2015-2020 (USD/MT)
Table 48. Global Oxaliplatin Sales by Application (2015-2020) (MT)
Table 49. Global Oxaliplatin Sales Share by Application (2015-2020)
Table 50. Global Oxaliplatin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 51. Global Oxaliplatin Revenue Share by Application (2021-2026)
Table 52. Global Oxaliplatin Price (MT) by Application (2021-2026)
Table 53. North America Oxaliplatin Sales by Company (2015-2020) (MT)
Table 54. North America Oxaliplatin Sales Market Share by Company (2015-2020)
Table 55. North America Oxaliplatin Sales by Type (2015-2020) (MT)
Table 56. North America Oxaliplatin Sales Market Share by Type (2015-2020)
Table 57. North America Oxaliplatin Sales by Application (2015-2020) (MT)
Table 58. North America Oxaliplatin Sales Market Share by Application (2015-2020)
Table 59. North America Oxaliplatin Sales by Countries (2015-2020) (MT)
Table 60. North America Oxaliplatin Sales Market Share by Countries (2015-2020)
Table 61. North America Oxaliplatin Revenue by Countries (2015-2020) (Million US$)
Table 62. North America Oxaliplatin Revenue Market Share by Countries (2015-2020)
Table 63. Europe Oxaliplatin Sales by Company (2015-2020) (MT)
Table 64. Europe Oxaliplatin Sales Market Share by Company (2015-2020)
Table 65. Europe Oxaliplatin Sales by Type (2015-2020) (MT)
Table 66. Europe Oxaliplatin Sales Market Share by Type (2015-2020)
Table 67. Europe Oxaliplatin Sales by Application (2015-2020) (MT)
Table 68. Europe Oxaliplatin Sales Market Share by Application (2015-2020)
Table 69. Europe Oxaliplatin Sales by Countries (2015-2020) (MT)
Table 70. Europe Oxaliplatin Sales Market Share by Countries (2015-2020)
Table 71. Europe Oxaliplatin Revenue by Countries (2015-2020) (Million US$)
Table 72. Europe Oxaliplatin Revenue Market Share by Countries (2015-2020)
Table 73. Asia Pacific Oxaliplatin Sales by Regions (2015-2020) (MT)
Table 74. Asia Pacific Oxaliplatin Sales Market Share by Regions (2015-2020)
Table 75. Asia Pacific Oxaliplatin Sales by Type (2015-2020) (MT)
Table 76. Asia Pacific Oxaliplatin Sales Market Share by Type (2015-2020)
Table 77. Asia Pacific Oxaliplatin Sales by Application (2015-2020) (MT)
Table 78. Asia Pacific Oxaliplatin Sales Market Share by Application (2015-2020)
Table 79. Asia Pacific Oxaliplatin Sales by Countries (2015-2020) (MT)
Table 80. Asia Pacific Oxaliplatin Sales Market Share by Regions (2015-2020)
Table 81. Asia Pacific Oxaliplatin Revenue by Regions (2015-2020) (Million US$)
Table 82. Asia Pacific Oxaliplatin Revenue Market Share by Regions (2015-2020)
Table 83. Latin America Oxaliplatin Sales by Company (2015-2020) (MT)
Table 84. Latin America Oxaliplatin Sales Market Share by Company (2015-2020)
Table 85. Latin America Oxaliplatin Sales by Type (2015-2020) (MT)
Table 86. Latin America Oxaliplatin Sales Market Share by Type (2015-2020)
Table 87. Latin America Oxaliplatin Sales by Application (2015-2020) (MT)
Table 88. Latin America Oxaliplatin Sales Market Share by Application (2015-2020)
Table 89. Latin America Oxaliplatin Sales by Countries (2015-2020) (MT)
Table 90. Latin America Oxaliplatin Sales Market Share by Countries (2015-2020)
Table 91. Latin America Oxaliplatin Revenue by Countries (2015-2020) (Million US$)
Table 92. Latin America Oxaliplatin Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Oxaliplatin Sales by Type (2015-2020) (MT)
Table 94. Middle East and Africa Oxaliplatin Sales Market Share by Type (2015-2020)
Table 95. Middle East and Africa Oxaliplatin Sales by Application (2015-2020) (MT)
Table 96. Middle East and Africa Oxaliplatin Sales Market Share by Application (2015-2020)
Table 97. Middle East and Africa Oxaliplatin Sales by Countries (2015-2020) (MT)
Table 98. Middle East and Africa Oxaliplatin Sales Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Oxaliplatin Revenue by Countries (2015-2020) (Million US$)
Table 100. Middle East and Africa Oxaliplatin Revenue Market Share by Countries (2015-2020)
Table 101. Sanofi-Aventis Company Details
Table 102. Sanofi-Aventis Description and Business Overview
Table 103. Sanofi-Aventis Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Sanofi-Aventis Oxaliplatin Sales Growth Rate (2015-2020)
Table 105. Sanofi-Aventis Oxaliplatin Sales Market Share in Global Market
Table 106. Sanofi-Aventis Recent Development
Table 107. Yakult honsha Company Details
Table 108. Yakult honsha Description and Business Overview
Table 109. Yakult honsha Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Yakult honsha Oxaliplatin Sales Growth Rate (2015-2020)
Table 111. Yakult honsha Oxaliplatin Sales Market Share in Global Market
Table 112. Yakult honsha Recent Development
Table 113. Dr Reddy's laboratories Company Details
Table 114. Dr Reddy's laboratories Description and Business Overview
Table 115. Dr Reddy's laboratories Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. Dr Reddy's laboratories Oxaliplatin Sales Growth Rate (2015-2020)
Table 117. Dr Reddy's laboratories Oxaliplatin Sales Market Share in Global Market
Table 118. Dr Reddy's laboratories Recent Development
Table 119. Sun Pharmaceutical Company Details
Table 120. Sun Pharmaceutical Description and Business Overview
Table 121. Sun Pharmaceutical Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Sun Pharmaceutical Oxaliplatin Sales Growth Rate (2015-2020)
Table 123. Sun Pharmaceutical Oxaliplatin Sales Market Share in Global Market
Table 124. Sun Pharmaceutical Recent Development
Table 125. Teva Company Details
Table 126. Teva Description and Business Overview
Table 127. Teva Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Teva Oxaliplatin Sales Growth Rate (2015-2020)
Table 129. Teva Oxaliplatin Sales Market Share in Global Market
Table 130. Teva Recent Development
Table 131. Fresenius Kabi Company Details
Table 132. Fresenius Kabi Description and Business Overview
Table 133. Fresenius Kabi Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 134. Fresenius Kabi Oxaliplatin Sales Growth Rate (2015-2020)
Table 135. Fresenius Kabi Oxaliplatin Sales Market Share in Global Market
Table 136. Fresenius Kabi Recent Development
Table 137. Hospira Company Details
Table 138. Hospira Description and Business Overview
Table 139. Hospira Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 140. Hospira Oxaliplatin Sales Growth Rate (2015-2020)
Table 141. Hospira Oxaliplatin Sales Market Share in Global Market
Table 142. Hospira Recent Development
Table 143. Mylan Company Details
Table 144. Mylan Description and Business Overview
Table 145. Mylan Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 146. Mylan Oxaliplatin Sales Growth Rate (2015-2020)
Table 147. Mylan Oxaliplatin Sales Market Share in Global Market
Table 148. Mylan Recent Development
Table 149. Jiangsu Hengrui Medicine Company Details
Table 150. Jiangsu Hengrui Medicine Description and Business Overview
Table 151. Jiangsu Hengrui Medicine Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. Jiangsu Hengrui Medicine Oxaliplatin Sales Growth Rate (2015-2020)
Table 153. Jiangsu Hengrui Medicine Oxaliplatin Sales Market Share in Global Market
Table 154. Jiangsu Hengrui Medicine Recent Development
Table 155. Nanjing Pharmaceutical Factory Company Details
Table 156. Nanjing Pharmaceutical Factory Description and Business Overview
Table 157. Nanjing Pharmaceutical Factory Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Nanjing Pharmaceutical Factory Oxaliplatin Sales Growth Rate (2015-2020)
Table 159. Nanjing Pharmaceutical Factory Oxaliplatin Sales Market Share in Global Market
Table 160. Nanjing Pharmaceutical Factory Recent Development
Table 161. Jiangsu Aosaikang Pharmaceutical Company Details
Table 162. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 163. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 164. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Sales Growth Rate (2015-2020)
Table 165. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Sales Market Share in Global Market
Table 166. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 167. Qilu Pharmaceutical Company Details
Table 168. Qilu Pharmaceutical Description and Business Overview
Table 169. Qilu Pharmaceutical Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 170. Qilu Pharmaceutical Oxaliplatin Sales Growth Rate (2015-2020)
Table 171. Qilu Pharmaceutical Oxaliplatin Sales Market Share in Global Market
Table 172. Qilu Pharmaceutical Recent Development
Table 173. Hisun Pharmaceutical Company Details
Table 174. Hisun Pharmaceutical Description and Business Overview
Table 175. Hisun Pharmaceutical Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 176. Hisun Pharmaceutical Oxaliplatin Sales Growth Rate (2015-2020)
Table 177. Hisun Pharmaceutical Oxaliplatin Sales Market Share in Global Market
Table 178. Hisun Pharmaceutical Recent Development
Table 179. Lunan Pharmaceutical Company Details
Table 180. Lunan Pharmaceutical Description and Business Overview
Table 181. Lunan Pharmaceutical Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 182. Lunan Pharmaceutical Oxaliplatin Sales Growth Rate (2015-2020)
Table 183. Lunan Pharmaceutical Oxaliplatin Sales Market Share in Global Market
Table 184. Lunan Pharmaceutical Recent Development
Table 185. Luoxin Company Details
Table 186. Luoxin Description and Business Overview
Table 187. Luoxin Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 188. Luoxin Oxaliplatin Sales Growth Rate (2015-2020)
Table 189. Luoxin Oxaliplatin Sales Market Share in Global Market
Table 190. Luoxin Recent Development
Table 191. Halfsky Pharmacy Company Details
Table 192. Halfsky Pharmacy Description and Business Overview
Table 193. Halfsky Pharmacy Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 194. Halfsky Pharmacy Oxaliplatin Sales Growth Rate (2015-2020)
Table 195. Halfsky Pharmacy Oxaliplatin Sales Market Share in Global Market
Table 196. Halfsky Pharmacy Recent Development
Table 197. YRPG Company Details
Table 198. YRPG Description and Business Overview
Table 199. YRPG Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 200. YRPG Oxaliplatin Sales Growth Rate (2015-2020)
Table 201. YRPG Oxaliplatin Sales Market Share in Global Market
Table 202. YRPG Recent Development
Table 203. Hainan Jinrui Pharmaceutical Company Details
Table 204. Hainan Jinrui Pharmaceutical Description and Business Overview
Table 205. Hainan Jinrui Pharmaceutical Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 206. Hainan Jinrui Pharmaceutical Oxaliplatin Sales Growth Rate (2015-2020)
Table 207. Hainan Jinrui Pharmaceutical Oxaliplatin Sales Market Share in Global Market
Table 208. Hainan Jinrui Pharmaceutical Recent Development
Table 209. Jari Pharmaceutical Company Details
Table 210. Jari Pharmaceutical Description and Business Overview
Table 211. Jari Pharmaceutical Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 212. Jari Pharmaceutical Oxaliplatin Sales Growth Rate (2015-2020)
Table 213. Jari Pharmaceutical Oxaliplatin Sales Market Share in Global Market
Table 214. Jari Pharmaceutical Recent Development
Table 215. Chiatai Tianqing Company Details
Table 216. Chiatai Tianqing Description and Business Overview
Table 217. Chiatai Tianqing Oxaliplatin Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 218. Chiatai Tianqing Oxaliplatin Sales Growth Rate (2015-2020)
Table 219. Chiatai Tianqing Oxaliplatin Sales Market Share in Global Market
Table 220. Chiatai Tianqing Recent Development
Table 221. Oxaliplatin Distributors List
Table 222. Oxaliplatin Customers List
Table 223. Global Oxaliplatin Sales Forecast 2021-2026 (MT) & (Million US$)
Table 224. Global Oxaliplatin Sales Forecast by Type 2021-2026 (MT)
Table 225. Global Oxaliplatin Sales Forecast by Application 2021-2026 (MT)
Table 226. Global Oxaliplatin Sales Forecast by Regions 2021-2026 (MT)
Table 227. Global Oxaliplatin Revenue Forecast by Regions 2021-2026 (Million US$)
Table 228. North America Oxaliplatin Sales Forecast by Countries 2021-2026 (MT)
Table 229. North America Oxaliplatin Revenue Forecast by Countries 2021-2026
Table 230. Europe Oxaliplatin Sales Forecast by Countries 2021-2026 (MT)
Table 231. Europe Oxaliplatin Revenue Market Share Forecast by Countries 2021-2026
Table 232. Asia Pacific Oxaliplatin Sales Forecast by Regions 2021-2026 (MT)
Table 233. Asia Pacific Oxaliplatin Revenue Forecast by Regions 2021-2026 (Million US$)
Table 234. Latin America Oxaliplatin Sales Forecast by Countries 2021-2026 (MT)
Table 235. Latin America Oxaliplatin Revenue Forecast by Countries 2021-2026 (Million US$)
Table 236. Middle East and Africa Oxaliplatin Sales Forecast by Regions 2021-2026 (MT)
Table 237. Middle East and Africa Oxaliplatin Revenue Forecast by Regions 2021-2026 (Million US$)
Table 238. Research Programs/Design for This Report
Table 239. Key Data Information from Secondary Sources
Table 240. Key Data Information from Primary Sources
List of Figures
Figure 1. Oxaliplatin Product Picture
Figure 2. Global Oxaliplatin Sales Market Shar by Type 2015-2026
Figure 3. Mannitol Figures
Figure 4. Glucose Solution Figures
Figure 5. Lactose Solution Figures
Figure 6. Other Figures
Figure 7. Global Oxaliplatin Sales Market Share by Application in 2019 & 2026
Figure 8. Colorectal Cancer Use Case
Figure 9. Stomach Cancer Use Case
Figure 10. Ovarian Cancer Use Case
Figure 11. Other Use Case
Figure 12. Oxaliplatin Report Years Considered
Figure 13. Global Oxaliplatin Market Size 2015-2026 (Million US$)
Figure 14. Global Oxaliplatin Sales 2015-2020 (MT)
Figure 15. Global Oxaliplatin Market Size Market Share by Regions 2015-2020
Figure 16. Global Oxaliplatin Sales Market Share by Regions in 2019
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Oxaliplatin Sales Share by Manufacturers in 2019
Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Oxaliplatin Sales in 2019
Figure 20. Oxaliplatin Value Share by Manufacturers in 2019
Figure 21. Oxaliplatin Revenue Share by Manufacturers In 2019
Figure 22. Oxaliplatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Oxaliplatin Revenue Share by Type (2015-2020)
Figure 24. Global Oxaliplatin Revenue Growth Rate by Type in 2015 & 2019
Figure 25. Global Oxaliplatin Market Share by Price Range (2015-2020)
Figure 26. Global Oxaliplatin Revenue Share by Application (2015-2020)
Figure 27. Global Oxaliplatin Revenue Growth Rate by Application in 2015 & 2019
Figure 28. North America Oxaliplatin Revenue Growth Rate 2015-2020 (Million US$)
Figure 29. U.S. Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 30. Canada Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 31. Europe Oxaliplatin Revenue Growth Rate 2015-2020 (Million US$)
Figure 32. Germany Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 33. France Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 34. U.K. Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 35. Italy Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 36. Russia Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 37. Asia Pacific Oxaliplatin Revenue Growth Rate 2015-2020 (Million US$)
Figure 38. China Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 39. Japan Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 40. South Korea Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 41. India Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 42. Australia Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 43. Taiwan Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 44. Indonesia Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 45. Thailand Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 46. Malaysia Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 47. Philippines Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 48. Vietnam Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 49. Latin America Oxaliplatin Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Mexico Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 51. Brazil Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 52. Argentina Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 53. Middle East and Africa Oxaliplatin Revenue Growth Rate 2015-2020 (Million US$)
Figure 54. Turkey Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 55. Saudi Arabia Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 56. U.A.E Oxaliplatin Sales Growth Rate (2015-2020) (MT)
Figure 57. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Yakult honsha Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Dr Reddy's laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Hospira Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Jiangsu Hengrui Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Nanjing Pharmaceutical Factory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Jiangsu Aosaikang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Qilu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Hisun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Lunan Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Luoxin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. Halfsky Pharmacy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 73. YRPG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 74. Hainan Jinrui Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 75. Jari Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 76. Chiatai Tianqing Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. Oxaliplatin Value Chain
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. North America Oxaliplatin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 81. North America Oxaliplatin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 82. Europe Oxaliplatin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 83. Europe Oxaliplatin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 84. Asia Pacific Oxaliplatin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 85. Asia Pacific Oxaliplatin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 86. Latin America Oxaliplatin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 87. Latin America Oxaliplatin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 88. Middle East and Africa Oxaliplatin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 89. Middle East and Africa Oxaliplatin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed


【掲載企業】

Sanofi-Aventis、Yakult honsha、Dr Reddy's laboratories、Sun Pharmaceutical、Teva、Fresenius Kabi、Hospira、Mylan、Jiangsu Hengrui Medicine、Nanjing Pharmaceutical Factory、Jiangsu Aosaikang Pharmaceutical、Qilu Pharmaceutical、Hisun Pharmaceutical、Lunan Pharmaceutical、Luoxin、Halfsky Pharmacy、YRPG、Hainan Jinrui Pharmaceutical、Jari Pharmaceutical、Chiatai Tianqing

★調査レポート[世界のオキサリプラチン市場:成長動向・競争分析2020-2026] (コード:QYR20AP01716)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のオキサリプラチン市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆